Primary Lateral Sclerosis: A Motor Neuron Disease That Is Not ALS — and Why That Difference Matters Enormously

Both PLS and ALS are motor neuron diseases, but they affect different parts of the motor system. ALS damages both the upper motor neurons (in the brain) and the lower motor neurons (in the spinal cord), causing both spasticity and muscle wasting, and leading to respiratory failure. PLS affects only the upper motor neurons — the lower motor neurons and the muscles are spared direct damage. This means PLS does not cause muscle wasting, does not cause the respiratory failure that shortens life in ALS, and progresses much more slowly. Many people with true PLS live for many years or decades after diagnosis, often dying from an unrelated cause.

A confident diagnosis of PLS typically requires at least three to four years of symptom observation and this is intentional, not a failing of the system. The reason is that early ALS can look identical to PLS, presenting with purely upper motor neuron signs before the lower motor neuron involvement becomes evident. Only by following the patient carefully over time with repeated neurological examinations and EMG studies confirming continued absence of lower motor neuron signs — can a true PLS diagnosis be made with confidence. At KIMS Neuroscience, Hyderabad, we are transparent with patients about this diagnostic timeline and provide the serial assessment needed to reach the most accurate diagnosis.

True PLS does not typically shorten life in the way ALS does. Most people with PLS do not develop respiratory failure the breathing muscles are generally spared because they are controlled by lower motor neurons that remain intact in PLS. Serious complications that can arise relate primarily to the mechanical consequences of spasticity falls and fall injuries, and in the later stages, difficulty swallowing that can lead to aspiration pneumonia. With the right management — spasticity treatment, falls prevention, and swallowing monitoring these risks can be significantly reduced. Many PLS patients live for many years with their condition.

This is the question that most worries families after a PLS diagnosis, and the honest answer is: some people initially diagnosed with PLS do go on to develop lower motor neuron signs and receive a revised diagnosis of ALS. Studies suggest that over long follow-up, a proportion of PLS patients estimates vary between studies develop lower motor neuron involvement. This is why the diagnosis of PLS must be made carefully, only after an adequate observation period, and why regular follow-up with neurological assessment and EMG is essential in the first few years. If lower motor neuron signs develop, the diagnosis is revised and management adjusts accordingly. If years pass without lower motor neuron involvement, the diagnosis of PLS becomes increasingly secure.

Spasticity is an involuntary increase in muscle tone the muscles feel permanently tight and resist being stretched. In PLS, spasticity in the legs makes walking feel as if you are pushing against resistance, makes the legs feel heavy, and makes normal fluid movement impossible. Climbing stairs, getting up from a chair, and walking on uneven surfaces become increasingly effortful and slow. Painful muscle cramps particularly at night are common. Spasticity also increases the risk of falls. Managing spasticity with medication (baclofen, tizanidine) and regular physiotherapy (particularly stretching) is the most important treatment priority in PLS.

Yes — as PLS progresses and spreads upward from the legs to involve the bulbar muscles (the muscles of the throat, tongue, and mouth), speech and swallowing are eventually affected in many patients. Speech becomes slower, less precisely articulated, and harder to understand. Swallowing difficulties can develop in the later stages. Unlike in ALS, where bulbar involvement can appear early and progress rapidly, in PLS these problems typically develop much later in the disease course. Speech therapy assessment and intervention, started early, can maintain communication function for significantly longer.

In adults, PLS is not considered directly hereditary. The overwhelming majority of adult-onset PLS cases are sporadic occurring without any family history and without a confirmed genetic cause. A rare juvenile form of PLS (beginning in childhood) is linked to mutations in the ALS2 gene, but this is a distinct condition. For adult patients, having a family member with PLS does not significantly increase your own risk. Genetic testing is offered at KIMS when a family history of neurological conditions raises the possibility of hereditary spastic paraplegia (HSP), a genetically distinct condition that can produce a similar clinical picture.

The most useful assistive devices depend on the stage and pattern of the disease. In early PLS, a walking stick or forearm crutches may help with balance and reduce the effort of walking. As spasticity progresses, ankle-foot orthoses (AFOs) — custom-made splints that support the ankle and foot — significantly improve walking safety and reduce tripping. A walking frame provides greater stability in later stages. For people with significant arm involvement, adaptive equipment for daily tasks ergonomic kitchen tools, voice-controlled technology, modified writing instruments extends independence. Our occupational therapist at KIMS assesses each patient's specific needs and recommends the most appropriate solutions at each stage.